Monte Rosa Therapeutics, Inc. · NASDAQ:GLUE

Montanova Capital, LLC reported a 5.50% stake in Monte Rosa Therapeutics, Inc. (Schedule 13G)

Event Apr 9, 2025 · Filed Apr 16, 2025

Montanova Capital, LLC reported a 5.50% stake in Monte Rosa Therapeutics, Inc., 3,360,000 shares, as a passive investor on Apr 9, 2025. Filed Apr 16, 2025 (Schedule 13G).

Stake
5.50%
Shares
3,360,000
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
SUVRETTA CAPITAL MANAGEMENT, LLC5.50%3,360,000
Averill Master Fund, Ltd.5.10%3,147,448
Aaron Cowen5.50%3,360,000

Source

View original at SEC

Related